Advancements and Toxicities in Metastatic Breast Cancer Treatments

This chapter explores treatment strategies for premenopausal women with hormone receptor positive metastatic breast cancer, emphasizing ovarian suppression and a new triplet therapy for PIK3CA mutations. It also addresses the side effects of CDK4-6 inhibitors and presents useful tips for remembering toxicities in clinical settings.

Transcript

Play full episode

Remember Everything You Learn from Podcasts

Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.

Get the app